Report: FDA looks into time gap between gene therapy data manipulation discovery, launch of formal probe

0
9


The Wall Street Journal reported that the agency was focusing on the two-month delay between the March 14 discovery of data manipulation by Novartis’ AveXis unit regarding the therapy Zolgensma and its May 15 launch of a formal inquiry into the matter.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here